Drugs that contain Follitropin Alfa/beta
1. Follistim patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767251 | ORGANON USA INC | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) | |
Market Authorisation Date: 29 September, 1997
Treatment: NA
Dosage: INJECTABLE;IM-SC
More Information on Dosage
FOLLISTIM family patents
2. Follistim Aq patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767251 | ORGANON USA INC | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) | |
| US5929028 | ORGANON USA INC | Liquid gonadotropin containing formulations |
Jan, 2018
(6 years ago) | |
| US7563763 | ORGANON USA INC | FSH and FSH variant formulations, products and methods |
Aug, 2019
(4 years ago) | |
| US7446090 | ORGANON USA INC | FSH formulation |
Aug, 2019
(4 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-306) | Jun 28, 2013 |
| New Dosing Schedule(D-133) | Aug 22, 2014 |
Market Authorisation Date: 11 February, 2004
Treatment: Treatment of infertility through induction of ovulation and pregnancy to anovulatory infertile women; Method of treating infertility
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
FOLLISTIM AQ family patents
3. Gonal-f patents
expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767251 | EMD SERONO | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) | |
| US5767067 | EMD SERONO | Follicle stimulating hormone and pharmaceutical compositions containing same |
Jun, 2015
(8 years ago) | |
| US7563763 | EMD SERONO | FSH and FSH variant formulations, products and methods |
Aug, 2019
(4 years ago) | |
Market Authorisation Date: 28 February, 2001
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
GONAL-F family patents
4. Gonal-f Rff patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767067 | EMD SERONO | Follicle stimulating hormone and pharmaceutical compositions containing same |
Jun, 2015
(8 years ago) | |
| US5767251 | EMD SERONO | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) | |
Market Authorisation Date: 25 March, 2004
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
GONAL-F RFF family patents
5. Gonal-f Rff Pen patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767251 | EMD SERONO | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) | |
| US5767067 | EMD SERONO | Follicle stimulating hormone and pharmaceutical compositions containing same |
Jun, 2015
(8 years ago) | |
| US7446090 | EMD SERONO | FSH formulation |
Aug, 2019
(4 years ago) | |
| US7741268 | EMD SERONO | Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant |
Apr, 2024
(a month ago) | |
Market Authorisation Date: 25 November, 2019
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
GONAL-F RFF PEN family patents